Creator Complex
This article was originally published in Start Up
Executive Summary
With $5 million in funding from PE Corp. and another $30-$35 million to be raised through limited partners, Noubar Afeyan, PhD, the founder of PerSeptive Biosystems, has formed a new seed fund, Newcogen, to invest in life sciences and information technologies. The new fund will create companies around concepts, acting as a cross between a seed stage fund, an incubator, and an entrepreneur-in-residence program.
You may also be interested in...
EngeneOS Inc.
Boston-area start-up engeneOS Inc. aspires to build molecular machines with starting materials that come from nature. The firm aims to take advantage of the the fact that proteins and nucleic acids have evolved highly specific capabilities over thousands of years. Management sees them as components that can be catalogued, combined and harnessed to carry out new tasks.
Wound Solutions Ltd.
Wound Solutions Ltd. looks to the paradigm of patient self-care in diabetes to address the gaps in chronic wound care, where the feedback provided by blood glucose monitoring encourages changes in behavior. A small device that is placed under a compression bandage helps patients with venous leg ulcers comply with the steps they should be taking to support wound healing, in the process, collecting data that helps clinicians make informed therapy decisions.
Patient-Centric Devices Promise Cost-Efficient Advanced Wound Care
The treatment of chronic wounds is challenging, not only because of the underlying biology, but also because of more practical considerations: fragmentation in the care settings, the logistics of delivering products to patients, and the costs of chronic care. Next generation advanced wound care companies are engineering solutions to these problems.